BRIEF—Boehringer Ingelheim appoints new CMO

Privately-held German firm Boehringer Ingelheim has appointed Mehdi Shahidi as chief medical officer, replacing Thor Voigt, who will retire after 27 years at the firm.

Dr Shahidi joined Boehringer Ingelheim in 2005 as a clinical development lead for oncology, taking on roles of increasing responsibility in the following years.

Prior to joining the pharmaceutical industry, he had a career in clinical research.